z-logo
open-access-imgOpen Access
An optimal control approach for enhancing natural killer cells' secretion of cytolytic molecules
Author(s) -
Sahak Z. Makaryan,
Stacey D. Finley
Publication year - 2020
Publication title -
apl bioengineering
Language(s) - English
Resource type - Journals
ISSN - 2473-2877
DOI - 10.1063/5.0024726
Subject(s) - cytolysis , perforin , microbiology and biotechnology , secretion , effector , biology , cytolysin , granzyme b , granzyme , natural killer cell , cytotoxicity , immunology , immune system , t cell , biochemistry , in vitro , cd8 , virulence , gene
Natural killer (NK) cells are immune effector cells that can detect and lyse cancer cells. However, NK cell exhaustion, a phenotype characterized by reduced secretion of cytolytic models upon serial stimulation, limits the NK cell's ability to lyse cells. In this work, we investigated in silico strategies that counteract the NK cell's reduced secretion of cytolytic molecules. To accomplish this goal, we constructed a mathematical model that describes the dynamics of the cytolytic molecules granzyme B (GZMB) and perforin-1 (PRF1) and calibrated the model predictions to published experimental data using a Bayesian parameter estimation approach. We applied an information-theoretic approach to perform a global sensitivity analysis, from which we found that the suppression of phosphatase activity maximizes the secretion of GZMB and PRF1. However, simply reducing the phosphatase activity is shown to deplete the cell's intracellular pools of GZMB and PRF1. Thus, we added a synthetic Notch (synNotch) signaling circuit to our baseline model as a method for controlling the secretion of GZMB and PRF1 by inhibiting phosphatase activity and increasing production of GZMB and PRF1. We found that the optimal synNotch system depends on the frequency of NK cell stimulation. For only a few rounds of stimulation, the model predicts that inhibition of phosphatase activity leads to more secreted GZMB and PRF1; however, for many rounds of stimulation, the model reveals that increasing production of the cytolytic molecules is the optimal strategy. In total, we developed a mathematical framework that provides actionable insight into engineering robust NK cells for clinical applications.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom